Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 2
3(100.0%)
3Total
Phase 2(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04662632Phase 2Completed

Abbreviated Protocol for Two-Stage Exchange

Role: lead

NCT06383611Unknown

Expanded Access to Cyclic Irrigation in Patients Undergoing Exchange Arthroplasty

Role: lead

NCT05607030Phase 2Completed

A Second Trial of the Abbreviated Protocol Two-Stage Exchange

Role: lead

NCT03721328Phase 2Completed

Safety and Efficacy in Patients Treated for Hip or Knee PJI With Vancomycin and Tobramycin Joint Irrigation

Role: lead

All 4 trials loaded